FDA issued a Warning Letter to Fagron, Inc on 8/29/2018 for a later inspection.
483 Fagron Feb 2002

483 Fagron Feb 2002

Marie Fadden FDA$119.00 - Available Now

FDA investigators audited the Fagron - Saint Paul, MN, United States facility and issued inspectional observations (via FDA 483) on 19 Feb 2002.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Feb 2002
  • Location: Saint Paul, United States
  • FEI: 1000174332
Add To Cart